These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9261093)

  • 41. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.
    Hansen K; Farkas T; Lukas J; Holm K; Rönnstrand L; Bartek J
    EMBO J; 2001 Feb; 20(3):422-32. PubMed ID: 11157749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
    Ikeda MA; Nevins JR
    Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta.
    Hu X; Zuckerman KS
    Leuk Lymphoma; 2000 Jul; 38(3-4):235-46. PubMed ID: 10830731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
    Zhu L; Harlow E; Dynlacht BD
    Genes Dev; 1995 Jul; 9(14):1740-52. PubMed ID: 7622038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
    Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.
    Law BK; Chytil A; Dumont N; Hamilton EG; Waltner-Law ME; Aakre ME; Covington C; Moses HL
    Mol Cell Biol; 2002 Dec; 22(23):8184-98. PubMed ID: 12417722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.
    Zalvide J; DeCaprio JA
    Mol Cell Biol; 1995 Oct; 15(10):5800-10. PubMed ID: 7565733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
    Yu B; Lane ME; Wadler S
    Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
    Zhang K; Kumar R
    Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth.
    Graña X; Garriga J; Mayol X
    Oncogene; 1998 Dec; 17(25):3365-83. PubMed ID: 9916999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
    Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
    Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. pRB, p107 and p130 as transcriptional regulators: role in cell growth and differentiation.
    Mayol X; Graña X
    Prog Cell Cycle Res; 1997; 3():157-69. PubMed ID: 9580269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor.
    Castaño E; Kleyner Y; Dynlacht BD
    Mol Cell Biol; 1998 Sep; 18(9):5380-91. PubMed ID: 9710622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.
    Moberg K; Starz MA; Lees JA
    Mol Cell Biol; 1996 Apr; 16(4):1436-49. PubMed ID: 8657117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
    Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
    Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.